Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DEV Lactose Broth

<strong>DEV Lactose Broth</strong>_x000D_ <strong>Catalog number:</strong> B2013861_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 250 g_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Granules_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> DEV Lactose broth_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Eyjolfsson R. Lisinopril-lactose incompatibility Drug Dev Ind Pharm. 1998 Aug;24(8):797-8._x000D_ 2: Abu Fara D, Rashid I, Alkhamis K, Al-Omari M, Chowdhry BZ, Badwan A. Modification of -lactose monohydrate as a direct compression excipient using roller compaction Drug Dev Ind Pharm. 2018 Dec;44(12):2038-2047._x000D_ 3: Salstio PJ, Machado M, Nunes T, Sousa E Silva JP, Costa PC. Lactose monohydrate flow characterization using shear cell method Pharm Dev Technol. 2020 Jul;25(6):686-693._x000D_ 4: Faulhammer E, Kruisz J, Scheibelhofer O, Rehrl J, Witschnigg A, Khinast JG. Filling of lactose-based formulations in a tamping-pin capsule filler Drug Dev Ind Pharm. 2020 May;46(5):775-787._x000D_ 5: Patil S, Mahadik A, Nalawade P, More P. Crystal engineering of lactose using electrospray technology: carrier for pulmonary drug delivery Drug Dev Ind Pharm. 2017 Dec;43(12):2085-2091._x000D_ 6: Vilotte JL. Lowering the milk lactose content in vivo: potential interests, strategies and physiological consequences Reprod Nutr Dev. 2002 Mar-Apr;42(2):127-32._x000D_ 7: Chin WC, Chan LW, Heng PW. A mechanistic investigation on the utilization of lactose as a protective agent for multi-unit pellet systems Pharm Dev Technol. 2016 Mar;21(2):222-30._x000D_ 8: Persson AS, Pazesh S, Alderborn G. Tabletability and compactibility of -lactose monohydrate powders of different particle size. I. Experimental comparison Pharm Dev Technol. 2022 Mar;27(3):319-330._x000D_ 9: Llusa M, Levin M, Snee RD, Muzzio FJ. Shear-induced APAP de-agglomeration Drug Dev Ind Pharm. 2009 Dec;35(12):1487-95._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33492999">10: Aljohani M, McArdle P, Erxleben A. Dual-drug amorphous formulation of gliclazide Drug Dev Ind Pharm. 2021 Feb;47(2):302-307. </a>_x000D_ _x000D_ <strong>Products Related to DEV Lactose Broth can be found at</strong> <a href="https://moleculardepot.com/product-category/Media/"> Media</a>

Product Specifications

Short Description

Catalog Number: B2013861 (250 g)

Weight

5.5

Length

5

Width

3

Height

3

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
BNC470040-500 1x 500 µL

CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD43 (84-3C1), CF640R conjugate, 0.1mg/mL
BNC400342-100 1x 100 µL

CD43 (84-3C1), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL
BNC940096-100 1x 100 µL

Histone H1 (AE-4), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MAGE A1 (MA454), CF740 conjugate, 0.1mg/mL
BNC740008-500 1x 500 µL

MAGE A1 (MA454), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD47 (B6H12.2), CF568 conjugate, 0.1mg/mL
BNC680437-500 1x 500 µL

CD47 (B6H12.2), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HSP27 (G3.1), CF405S conjugate, 0.1mg/mL
BNC040861-100 1x 100 µL

HSP27 (G3.1), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details